Skip to content
Stock screener

HOWL

Conviction 76HealthcareScan · Mon, Oct 19, 2026

Werewolf Therapeutics, Inc. (HOWL) closed at $1.04 (+6.12%) on Oct 19, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 67, RS Rating 99, -41.2% from its 52-week high, +61.3% year to date. Sector: Healthcare · Pharmaceutical Preparations.

HOWL$1.04+6.12%
ResistanceSupportVol 14Insider sell
63 bars

Price chart, 63 bars from Wed, Jul 22, 2026 to Mon, Oct 19, 2026. Last close $1.04, high $1.05, low $0.3400.

Vol MA14 495.19K
Jul 22Aug 7Aug 26Sep 14Oct 1Oct 19

Why HOWL moved

From the StockSetups movers recaps that covered HOWL, newest first. A recap states what was known that day.

Werewolf Therapeutics, Inc.Pharmaceutical Preparationswww.werewolftx.com ↗
Price1.04
Change+6.12%
Gap+1.29%
Rel volume—
Avg volume499.2K
Avg $ vol476.13K
SMA 200.9557
SMA 500.8549
SMA 2000.6632
Price vs 50+21.65%
Price vs 200+56.81%
MA stackbullish
50/200 cross—
Supertrendup · 0.8714
RSI (14)67
MACD hist0.00
MACD crossbull · 0d
Stoch %K / %D94 / 81
ADX (14)45
+DI / −DI28 / 8
RSI divergence—
MACD divergence—
ATR %4.90%
ADR %4.38%
52w high1.77
52w low0.3080
From 52w high-41.24%
Above 52w low+237.66%
New 52w highNo
SqueezeFired
Bollinger width16.32%
%B1.04
Donchian pos94.12%
Donchian high1.05
Donchian low0.8800
AVWAP (52w high)0.8088
vs AVWAP high+28.59%
AVWAP (52w low)0.8219
vs AVWAP low+26.54%
OBV trendFlat
Chaikin MF (20)-0.07
Today vs 20d—
Avg vol (14d)495.19K
Avg vol (20d)499.2K
Avg $ vol (20d)476.13K
Market cap50.54M
RS Rating99 / 99
RS 3m (vs SPY)+184.05%
RS 6m (vs SPY)-0.92%
RS line new highYes
Trend template7/8
Technical rank94.2
1 week+5.93%
1 month+7.77%
3 months+186.50%
6 months+7.25%
1 year-37.72%
YTD+61.29%
P/E-0.83
P/B3.10
P/S—
P/FCF-0.84
EPS-1.33
Div yield—
ROE-373.32%
ROA-251.80%
Debt/Eq1.97
Current2.91
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth13.75%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value60.64M
Revenue—
Net income3.67M
Gross profit—
Free cash flow-60.29M
IndustryPharmaceutical Preparations
ExchangeNasdaq
Shares out48.6M
Employees14
ListedFri, Apr 30, 2021
Free float36.17M
Float %74.4%
Short interest1.67M
Days to cover0.1d
Short volume53.0%
Squeeze score18 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeA
Conviction76 / 100
Pattern quality—
Tech rank94.2 / 100
Group rank14 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance1.04
Support0.8900
Days since event—
Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in HOWL

All disclosures →
No recent disclosed trades by Congress in HOWL. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in HOWL · open-market 10 sells

InsiderSideShares
EVNIN LUKE
Director · Common Stock · 2026-07-07
Sell107.43K
EVNIN LUKE
Director · Common Stock · 2026-07-06
Sell35.77K
EVNIN LUKE
Director · Common Stock · 2026-06-29
Sell157.08K
RA CAPITAL MANAGEMENT, L.P.
10% owner · Common Stock · 2026-06-17
Sell27.7K
RA CAPITAL MANAGEMENT, L.P.
10% owner · Common Stock · 2026-06-17
Sell389.22K
EVNIN LUKE
Director · Common Stock · 2026-06-09
Sell76.93K
EVNIN LUKE
Director · Common Stock · 2026-06-08
Sell60.55K
EVNIN LUKE
Director · Common Stock · 2026-06-05
Sell24.95K
EVNIN LUKE
Director · Common Stock · 2026-06-04
Sell20.07K
EVNIN LUKE
Director · Common Stock · 2026-06-03
Sell29.75K

SEC filings

EDGAR filings in HOWL · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.